GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Andros Pharmaceuticals Co Ltd (ROCO:6917) » Definitions » Forward Dividend Yield %

Andros Pharmaceuticals Co (ROCO:6917) Forward Dividend Yield % : 0.00% (As of Dec. 13, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Andros Pharmaceuticals Co Forward Dividend Yield %?

As of today (2024-12-13), the Forward Annual Dividend Yield of Andros Pharmaceuticals Co is 0.00%.

As of today (2024-12-13), the Trailing Annual Dividend Yield of Andros Pharmaceuticals Co is 0.00%.

ROCO:6917's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.5
* Ranked among companies with meaningful Forward Dividend Yield % only.

Andros Pharmaceuticals Co's Dividends per Share for the six months ended in Jun. 2024 was NT$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Andros Pharmaceuticals Co's Forward Dividend Yield %

For the Biotechnology subindustry, Andros Pharmaceuticals Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Andros Pharmaceuticals Co's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Andros Pharmaceuticals Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Andros Pharmaceuticals Co's Forward Dividend Yield % falls into.



Andros Pharmaceuticals Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Andros Pharmaceuticals Co  (ROCO:6917) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Andros Pharmaceuticals Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Andros Pharmaceuticals Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Andros Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 22, Sec. 2, Shengyi Road, 6th Floor, Building D, Biotech Building, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei City, TWN, 30261
Andros Pharmaceuticals Co Ltd is a biopharmaceutical company engaged in developing novel drug delivery platform technologies. The firm focuses on the development of topical new dosage forms and non-viral gene delivery systems, with the current pipeline indicated for pain management, DNA repair, and gene therapy. Its product line comprises New Dosage Forms (Topical), Super Generics (Topical), High-End Cosmetic Ingredients (Topical), and Gene Delivery Systems (Injectable).

Andros Pharmaceuticals Co Headlines

No Headlines